MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study

著者: Phil Ambery, Victoria E R Parker, Michael Stümvoll, Maximilian Posch, Tim Heise, Leona Plum-Moerschel, Lan-Feng Tsai, Darren Robertson, Meena Jain, Marcella Petrone, Cristina M. Rondinone, Boaz Hirshberg, Lutz Jermutus - The Lancet 2018 被引用: 295